1. Alginate-based microcapsules with galactosylated chitosan internal for primary hepatocyte applications.
- Author
-
Lou R, Xie H, Zheng H, Ren Y, Gao M, Guo X, Song Y, Yu W, Liu X, and Ma X
- Subjects
- Alginates pharmacology, Animals, Asialoglycoproteins metabolism, Biological Transport, Capsules, Cell Survival drug effects, Glucuronic Acid chemistry, Glucuronic Acid metabolism, Glucuronic Acid pharmacology, Hepatocytes cytology, Hepatocytes drug effects, Hexuronic Acids chemistry, Hexuronic Acids metabolism, Hexuronic Acids pharmacology, Male, Mechanical Phenomena, Molecular Weight, Permeability, Polylysine chemistry, Rats, Rats, Sprague-Dawley, Solubility, Water chemistry, Alginates chemistry, Alginates metabolism, Chitosan chemistry, Galactose chemistry, Hepatocytes metabolism
- Abstract
Alginate-galactosylated chitosan/polylysine (AGCP) microcapsules with excellent stability and high permeability were developed and employed in primary hepatocyte applications. The galactosylated chitosan (GC), synthesized via the covalent coupling of lactobionic acid (LA) with low molecular weight and water-soluble chitosan (CS), was ingeniously introduced into the core of alginate microcapsules by regulating the pH of gelling bath. The internal GC of the microcapsules simultaneously provided a large number of binding sites for the hepatocytes and further promoted the hepatocyte-matrix interactions via the recognition of asialoglycoprotein receptors (ASGPRs) on the hepatocyte surface, and afforded the AGCP microcapsules an excellent stability via the electrostatic interactions with alginate. As a consequence, primary hepatocytes in AGCP microcapsules demonstrated enhanced viability, urea synthesis, albumin secretion, and P-450 enzyme activity, showing great prospects for hepatocyte applications in microcapsule system., (Copyright © 2016 Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF